Thursday, November 22, 2012

Let's see! Roche pledges to release Tamiflu data


The company told the Financial Times: “Roche plans to set up a multi-party advisory board comprising experts from academia and private institutions, including the Cochrane Collaboration, to review the totality of Tamiflu data with the objective to agree on a statistical analysis plan outlining the types of analyses that would be useful in a public health discussion on Tamiflu.”

Posted via email from Jack's posterous

No comments: